327 related articles for article (PubMed ID: 19789070)
21. Post-injury administration of minocycline: an effective treatment for nerve-injury induced neuropathic pain.
Mei XP; Xu H; Xie C; Ren J; Zhou Y; Zhang H; Xu LX
Neurosci Res; 2011 Jul; 70(3):305-12. PubMed ID: 21515316
[TBL] [Abstract][Full Text] [Related]
22. Neural modulation by blocks and infusions.
Varrassi G; Paladini A; Marinangeli F; Racz G
Pain Pract; 2006 Mar; 6(1):34-8. PubMed ID: 17309707
[TBL] [Abstract][Full Text] [Related]
23. Topical Treatment of Peripheral Neuropathic Pain: Applying the Evidence.
Sommer C; Cruccu G
J Pain Symptom Manage; 2017 Mar; 53(3):614-629. PubMed ID: 28042075
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of neuropathic pain and their implications for the design of clinical trials.
Rowbotham MC
Neurology; 2005 Dec; 65(12 Suppl 4):S66-73. PubMed ID: 16385106
[TBL] [Abstract][Full Text] [Related]
25. Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain.
Hanlon KE; Herman DS; Agnes RS; Largent-Milnes TM; Kumarasinghe IR; Ma SW; Guo W; Lee YS; Ossipov MH; Hruby VJ; Lai J; Porreca F; Vanderah TW
Brain Res; 2011 Jun; 1395():1-11. PubMed ID: 21550594
[TBL] [Abstract][Full Text] [Related]
26. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
27. Neurotrophic molecules: strategies for designing effective therapeutic molecules in neurodegeneration.
Skaper SD; Walsh FS
Mol Cell Neurosci; 1998 Nov; 12(4-5):179-93. PubMed ID: 9828084
[TBL] [Abstract][Full Text] [Related]
28. Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy.
Haroutounian S; Nikolajsen L; Bendtsen TF; Finnerup NB; Kristensen AD; Hasselstrøm JB; Jensen TS
Pain; 2014 Jul; 155(7):1272-1279. PubMed ID: 24704366
[TBL] [Abstract][Full Text] [Related]
29. Flecainide reverses neuropathic pain and suppresses ectopic nerve discharge in rats.
Ichimata M; Kitano T; Ikebe H; Iwasaka H; Noguchi T
Neuroreport; 2001 Jul; 12(9):1869-73. PubMed ID: 11435914
[TBL] [Abstract][Full Text] [Related]
30. Painful neuropathy in subclinical hypothyroidism: clinical and neuropathological recovery after hormone replacement therapy.
Penza P; Lombardi R; Camozzi F; Ciano C; Lauria G
Neurol Sci; 2009 Apr; 30(2):149-51. PubMed ID: 19214379
[TBL] [Abstract][Full Text] [Related]
31. Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain.
Mika J; Osikowicz M; Rojewska E; Korostynski M; Wawrzczak-Bargiela A; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2009 Nov; 623(1-3):65-72. PubMed ID: 19766105
[TBL] [Abstract][Full Text] [Related]
32. Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain.
Takeda K; Muramatsu M; Chikuma T; Kato T
J Mol Neurosci; 2009 Nov; 39(3):380-90. PubMed ID: 19653132
[TBL] [Abstract][Full Text] [Related]
33. Local application of capsaicin alleviates mechanical hyperalgesia after spinal nerve transection.
Kim SM; Kim J; Kim E; Hwang SJ; Shin HK; Lee SE
Neurosci Lett; 2008 Mar; 433(3):199-204. PubMed ID: 18242851
[TBL] [Abstract][Full Text] [Related]
34. Treatment of neuropathic pain.
Jefferies K
Semin Neurol; 2010 Sep; 30(4):425-32. PubMed ID: 20941675
[TBL] [Abstract][Full Text] [Related]
35. Leading the charge--pioneering treatments in the fight against neuropathic pain.
Dickinson T; Lee K; Spanswick D; Munro FE
Trends Pharmacol Sci; 2003 Nov; 24(11):555-7. PubMed ID: 14607072
[TBL] [Abstract][Full Text] [Related]
36. What can we learn from failed neuropathic pain trials?
Polydefkis M; Raja SN
Neurology; 2008 Jan; 70(4):250-1. PubMed ID: 18209199
[No Abstract] [Full Text] [Related]
37. [Types of topical treatment for peripheral neuropathic pain : Mechanism of action and indications].
Baron R; Mahn F
Schmerz; 2010 Aug; 24(4):317-25. PubMed ID: 20628765
[TBL] [Abstract][Full Text] [Related]
38. [Peripheral neuropathic pain more researched than central].
Hansson P
Lakartidningen; 2008 Sep 24-30; 105(39):2700-5. PubMed ID: 18846880
[No Abstract] [Full Text] [Related]
39. Mechanistic stratification of antineuralgic agents.
Beydoun A; Backonja MM
J Pain Symptom Manage; 2003 May; 25(5 Suppl):S18-30. PubMed ID: 12694989
[TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
Ranoux D; Attal N; Morain F; Bouhassira D
Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
